These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period. White WB; Lacourciere Y; Davidai G Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889 [TBL] [Abstract][Full Text] [Related]
16. Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan. Smith DH; Dubiel R; Jones M Am J Cardiovasc Drugs; 2005; 5(1):41-50. PubMed ID: 15631537 [TBL] [Abstract][Full Text] [Related]
17. The Valsartan Antihypertensive Long-Term Use Evaluation trial: a study in contrasts. Sica DA Hypertension; 2006 Sep; 48(3):362-3. PubMed ID: 16864742 [No Abstract] [Full Text] [Related]
18. Effects of telmisartan 80 mg and valsartan 160 mg on ambulatory blood pressure in patients with essential hypertension. White WB; Lacourciere Y J Hypertens; 2004 Oct; 22(10):2035-6; author reply 2036-8. PubMed ID: 15361777 [No Abstract] [Full Text] [Related]
19. Ambulatory blood pressure response to once-daily fimasartan: an 8-week, multicenter, randomized, double-blind, active-comparator, parallel-group study in Korean patients with mild to moderate essential hypertension. Lee H; Kim KS; Chae SC; Jeong MH; Kim DS; Oh BH Clin Ther; 2013 Sep; 35(9):1337-49. PubMed ID: 23932463 [TBL] [Abstract][Full Text] [Related]
20. Hope in Life and Value of blood pressure control. Ruilope LM; Segura J J Hypertens; 2004 Dec; 22(12):2265-6. PubMed ID: 15614017 [No Abstract] [Full Text] [Related] [Next] [New Search]